[How I diagnose and treat pure red cell aplasia].
作者信息
Han B
机构信息
Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences, Beijing 100730, China.
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2020 Jan 14;41(1):5-9. doi: 10.3760/cma.j.issn.0253-2727.2020.01.002.
Abstract
摘要
相似文献
1
[How I diagnose and treat pure red cell aplasia].[我如何诊断和治疗纯红细胞再生障碍性贫血]
Zhonghua Xue Ye Xue Za Zhi. 2020 Jan 14;41(1):5-9. doi: 10.3760/cma.j.issn.0253-2727.2020.01.002.
2
Thymoma associated with pure red-cell aplasia: clinical features and prognosis.胸腺瘤伴纯红细胞再生障碍：临床特征与预后
Asian Cardiovasc Thorac Ann. 2002 Jun;10(2):150-4. doi: 10.1177/021849230201000213.
3
Non-Hodgkins lymphoma presenting as pure red cell aplasia.以纯红细胞再生障碍性贫血为表现的非霍奇金淋巴瘤。
J Assoc Physicians India. 1992 Nov;40(11):765-6.
4
Pure red cell aplasia and acute hepatitis during pregnancy.妊娠期纯红细胞再生障碍和急性肝炎
Gynecol Obstet Invest. 2002;53(2):112-3. doi: 10.1159/000053004.
5
Treatment of erythropoietin-induced pure red cell aplasia: a retrospective study.促红细胞生成素诱导的纯红细胞再生障碍性贫血的治疗：一项回顾性研究。
Lancet. 2004 May 29;363(9423):1768-71. doi: 10.1016/S0140-6736(04)16302-2.
6
Pure red-cell aplasia and epoetin therapy.纯红细胞再生障碍性贫血与促红细胞生成素治疗
N Engl J Med. 2004 Sep 30;351(14):1403-8. doi: 10.1056/NEJMoa040528.
7
Pure red cell aplasia induced by erythropoiesis-stimulating agents.促红细胞生成素诱导的纯红细胞再生障碍性贫血。
Clin J Am Soc Nephrol. 2008 Jan;3(1):193-9. doi: 10.2215/CJN.02440607.
8
Pure red cell aplasia--report of 11 cases from eastern Nepal.纯红细胞再生障碍性贫血——尼泊尔东部11例报告
Indian J Pathol Microbiol. 2003 Jul;46(3):405-8.
9
10
Pure red cell aplasia associated with carbamazepine.与卡马西平相关的纯红细胞再生障碍。
J Assoc Physicians India. 1998 Jul;46(7):655-6.
本文引用的文献
1
Successful treatment of refractory/relapsed acquired pure red cell aplasia with sirolimus.西罗莫司治疗难治/复发性获得性纯红细胞再生障碍性贫血的疗效观察。
Ann Hematol. 2018 Nov;97(11):2047-2054. doi: 10.1007/s00277-018-3431-5. Epub 2018 Jul 7.
2
Sirolimus for the treatment of multi-resistant pure red cell aplasia.西罗莫司用于治疗多重耐药性纯红细胞再生障碍性贫血。
Br J Haematol. 2019 Mar;184(6):1055-1058. doi: 10.1111/bjh.15245. Epub 2018 May 9.
3
Pure red cell aplasia.纯红细胞再生障碍性贫血。
Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):51-56. doi: 10.1182/asheducation-2016.1.51.
4
ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation.ABO血型不相合的异基因造血干细胞移植
Transfus Med Hemother. 2016 Jan;43(1):3-12. doi: 10.1159/000441507. Epub 2015 Oct 29.
5
Thymoma associated with autoimmune diseases: 85 cases and literature review.胸腺瘤合并自身免疫性疾病：85 例病例并文献复习。
Autoimmun Rev. 2016 Jan;15(1):82-92. doi: 10.1016/j.autrev.2015.09.005. Epub 2015 Sep 25.
6
Marrow failure: a window into ribosome biology.骨髓衰竭：核糖体生物学的一扇窗口。
Blood. 2014 Oct 30;124(18):2784-92. doi: 10.1182/blood-2014-04-526301. Epub 2014 Sep 18.
7
Role of lenalidomide in the management of myelodysplastic syndromes with del(5q) associated with pure red cell aplasia (PRCA).来那度胺在伴有纯红细胞再生障碍性贫血（PRCA）的5号染色体长臂缺失（del(5q)）的骨髓增生异常综合征治疗中的作用。
Ann Hematol. 2015 Mar;94(3):531-4. doi: 10.1007/s00277-014-2192-z. Epub 2014 Aug 20.
8
Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation.主要 ABO 不相合造血细胞移植中纯红细胞再生障碍的发生率和自然病程。
Br J Haematol. 2013 Mar;160(6):798-805. doi: 10.1111/bjh.12210. Epub 2013 Jan 18.
9
Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature.静脉注射免疫球蛋白治疗与人类细小病毒 B19 感染相关的纯红细胞再生障碍：10 例患者的回顾性研究及文献复习。
Clin Infect Dis. 2013 Apr;56(7):968-77. doi: 10.1093/cid/cis1046. Epub 2012 Dec 12.
10
Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights.接受促红细胞生成素治疗的慢性肾脏病患者的抗体介导性纯红细胞再生障碍：新见解。
Kidney Int. 2012 Apr;81(8):727-32. doi: 10.1038/ki.2011.500. Epub 2012 Feb 15.
Zotero 插件